NEW YORK (GenomeWeb) – NanoString Technologies said today that it has entered into a new $100 million term loan facility with the CR Group (CRG), a health care-focused investment firm.

NanoString will use an aggregate of $60 million in proceeds from an initial draw to refinance its existing CRG term loan facility, under which approximately $50 million is currently outstanding. NanoString will also use proceeds for working capital and general corporate purposes and for transaction-related fees and expenses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.